SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response
GHDx Entry last modified on: Mar 14, 2022
COVID-19
Dataset Records for COVID-19
Displaying 1051 - 1100 of 1564
Metodología de la Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19
GHDx Entry last modified on: Mar 14, 2022
Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study. Preprint
GHDx Entry last modified on: May 12, 2022
Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
GHDx Entry last modified on: Jan 31, 2024
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020
GHDx Entry last modified on: Jan 31, 2024
Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: Results from universal screening in a tertiary care center in Mexico City, Mexico
GHDx Entry last modified on: Jan 31, 2024
Clinical and Pregnancy Outcomes of Coronavirus Disease 2019 Among Hospitalized Pregnant Women in the United States
GHDx Entry last modified on: Apr 10, 2023
Obstetric Observatory BRAZIL - COVID-19: 1031 maternal deaths because of COVID-19 and the unequal access to health care services
GHDx Entry last modified on: Apr 10, 2023
Social determinants of health and coronavirus disease 2019 in pregnancy
GHDx Entry last modified on: Apr 10, 2023
Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany - Study protocol of the CORONA-MONITORING lokal study
GHDx Entry last modified on: Dec 12, 2023
Symptoms persisting after hospitalisation for COVID-19: 12 months interim results of the CO-FLOW study
GHDx Entry last modified on: Mar 22, 2024
Prevalence and Persistence of Symptoms in Adult COVID-19 Survivors 3 and 18 Months after Discharge from Hospital or Corona Hotels
GHDx Entry last modified on: Mar 22, 2024
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement
GHDx Entry last modified on: Mar 22, 2024
Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study
GHDx Entry last modified on: Mar 22, 2024
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
GHDx Entry last modified on: Mar 22, 2024
United Kingdom - England and Wales COVID-19 Deaths Registered Weekly, Provisional 2020-2022
Deaths registered weekly in England and Wales, provisional
A population-based study of the prevalence of COVID-19 infection in Espírito Santo, Brazil: methodology and results of the first stage. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands
GHDx Entry last modified on: Jan 31, 2024
Severe and fatal forms of COVID-19 in children
GHDx Entry last modified on: Mar 14, 2022
Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study
GHDx Entry last modified on: Jan 31, 2024
When lockdown policies amplify social inequalities in COVID-19 infections. Evidence from a cross-sectional population-based survey in France. Preprint
GHDx Entry last modified on: Mar 14, 2022
Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children
GHDx Entry last modified on: Feb 1, 2024
Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study
GHDx Entry last modified on: Jan 31, 2024
Influence of Race and Ethnicity on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Rates and Clinical Outcomes in Pregnancy
GHDx Entry last modified on: Jan 31, 2024
Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai, India, during June 29-July 19, 2020. Preprint.
GHDx Entry last modified on: Mar 14, 2022
[The experience of the study of seroprevalence to the SARS-CoV-2 virus in the population of the Irkutsk region during the COVID-19 outbreak]
Опыт исс ледования серопревалентности к вирусу SARS-CoV-2 населения Иркутск ой области в период вспышки COVID-19
Brazil - Severe Acute Respiratory Syndrome Database - including data from COVID-19 2020-2022
Severe Acute Respiratory Syndrome Database - including COVID-19 data
Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study. Preprint
GHDx Entry last modified on: Sep 21, 2021
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany
GHDx Entry last modified on: Jan 31, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery Unit
GHDx Entry last modified on: Jan 31, 2024
Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection
GHDx Entry last modified on: Jan 31, 2024
Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana. Preprint
GHDx Entry last modified on: May 12, 2022
Seroepidemiology of SARS-CoV-2 infections in an urban Nicaraguan population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: A community-based cross-sectional study, August 2020
GHDx Entry last modified on: Jan 31, 2024
Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19
GHDx Entry last modified on: Apr 10, 2023
The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic
GHDx Entry last modified on: Jun 5, 2024
Body Composition in Community-Dwelling Older Adults Before and After SARS-CoV-2 Infection: A Longitudinal Prospective Study in a Rural Village Struck by the Pandemic
GHDx Entry last modified on: Mar 14, 2022
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020
GHDx Entry last modified on: Jan 31, 2024
Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey
GHDx Entry last modified on: Feb 29, 2024
United Kingdom - England and Wales Deaths Registered Weekly 2022
Deaths registered weekly in England and Wales, provisional
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals. Preprint
GHDx Entry last modified on: Apr 14, 2022
Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City
GHDx Entry last modified on: Jan 31, 2024
Initial findings of universal screening for SARS-CoV-2 in women admitted for delivery in North Wales: a prospective multicentre cohort study
GHDx Entry last modified on: Jan 31, 2024
Coronavirus disease 2019 infection and placental histopathology in women delivering at term
GHDx Entry last modified on: Jan 31, 2024
Maternal death due to COVID-19
GHDx Entry last modified on: Apr 10, 2023
Subscribe